General Announcement::Announcement

Issuer & Securities

Issuer/ Manager
JUBILANT PHARMA LIMITED
Securities
JUBILANTP US$200M6%N240305 - XS1958658509 - KBSB
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
15-Jun-2021 22:19:22
Status
New
Announcement Sub Title
Announcement
Announcement Reference
SG210615OTHRB6NK
Submitted By (Co./ Ind. Name)
Shyam S. Bhartia
Designation
Chairman and Managing Director
Effective Date and Time of the event
15/06/2021 17:00:00
Description (Please provide a detailed description of the event in the box below)
Dear Sirs,

We enclose a communication pertaining to manufacturing partnership for US production of COVID-19 Vaccine candidate, COVAXIN by Jubilant HollisterStier LLC, a wholly owned subsidiary of the Company.

This is for your kind information and records.

Attachments

JPL_SGX_Disclosure_June_15_2021.pdf
Total size =957K